Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ · Healthcare
Citius Pharmaceuticals, Inc. Total Liabilities 2011–2022
Citius Pharmaceuticals, Inc. annual total liabilities history from 2011 to 2022. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Citius Pharmaceuticals, Inc. total liabilities as of September 30, 2022: 10.6M, a 9.61% increase year-over-year.
- Citius Pharmaceuticals, Inc. total liabilities for 2022 were 10.6M, a 9.61% increase from 2021.
- Citius Pharmaceuticals, Inc. total liabilities for 2021 were 9.6M, a 4.52% decrease from 2020.
- Citius Pharmaceuticals, Inc. total liabilities for 2020 were 10.1M, a 5.31% increase from 2019.
- Citius Pharmaceuticals, Inc. total liabilities for 2019 were 9.6M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Citius Pharmaceuticals, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2022 | $11 |
| 2021 | $10 |
| 2020 | $10 |
| 2019 | $10 |
| 2018 | $0 |
| 2017 | $2 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
Citius Pharmaceuticals, Inc. Total Liabilities — FAQ
Citius Pharmaceuticals, Inc. (CTXR) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTXR's total liabilities history?
The chart and table above show Citius Pharmaceuticals, Inc.'s total liabilities by year and by quarter, including the growth rate.